Fujian Aonong Biological Technology Group Incorporation Ltd (603363) — Net Asset Quality Index
Fujian Aonong Biological Technology Group Incorporation Ltd (603363) has a Net Asset Quality Index of 41.4% as of September 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of CN¥9.15 Billion minus total liabilities of CN¥5.36 Billion yields net assets of CN¥3.79 Billion. A higher index indicates a stronger, lower-leverage balance sheet. For live market cap and overall valuation, see Fujian Aonong Biological Technology Grou (603363) total market value.
Quality Index
Net Assets
Total Assets
Total Liabilities
Fujian Aonong Biological Technology Group Incorporation Ltd Net Asset Quality Index Over Time (2013–2024)
This chart shows how Fujian Aonong Biological Technology Group Incorporation Ltd's Net Asset Quality Index has evolved across 12 annual periods from 2013 to 2024. As of September 2025, the index stands at 41.4%, representing net assets of CN¥3.79 Billion against total assets of CN¥9.15 Billion CNY. See Fujian Aonong Biological Technology Grou (603363) net assets for net asset value and shareholders' equity analysis.
Annual Net Asset Quality Index for Fujian Aonong Biological Technology Group Incorporation Ltd (2013–2024)
The table below presents the year-by-year Net Asset Quality Index for Fujian Aonong Biological Technology Group Incorporation Ltd from 2013 to 2024, covering 12 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. Check 603363 strategic assets to equity ratio to assess the company's strategic physical and investment asset allocation.
| Year | Quality Index | Net Assets (CNY) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2024 | 32.2% | CN¥3.06 Billion | CN¥9.51 Billion | CN¥6.44 Billion | ▲ +35.9 pp |
| 2023 | -3.7% | CN¥-503.22 Million | CN¥13.63 Billion | CN¥14.13 Billion | ▼ -22.1 pp |
| 2022 | 18.4% | CN¥3.43 Billion | CN¥18.66 Billion | CN¥15.23 Billion | ▲ +5.6 pp |
| 2021 | 12.8% | CN¥2.19 Billion | CN¥17.10 Billion | CN¥14.91 Billion | ▼ -19.7 pp |
| 2020 | 32.5% | CN¥3.90 Billion | CN¥12.02 Billion | CN¥8.12 Billion | ▲ +6.4 pp |
| 2019 | 26.1% | CN¥1.28 Billion | CN¥4.92 Billion | CN¥3.64 Billion | ▼ -4.4 pp |
| 2018 | 30.5% | CN¥1.01 Billion | CN¥3.31 Billion | CN¥2.30 Billion | ▼ -7.5 pp |
| 2017 | 38.0% | CN¥965.55 Million | CN¥2.54 Billion | CN¥1.57 Billion | ▲ +3.4 pp |
| 2016 | 34.7% | CN¥593.75 Million | CN¥1.71 Billion | CN¥1.12 Billion | ▲ +1.7 pp |
| 2015 | 33.0% | CN¥445.39 Million | CN¥1.35 Billion | CN¥902.85 Million | ▲ +9.8 pp |
| 2014 | 23.2% | CN¥214.94 Million | CN¥926.86 Million | CN¥711.92 Million | ▲ +8.2 pp |
| 2013 | 15.0% | CN¥106.35 Million | CN¥710.45 Million | CN¥604.09 Million | — |